• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与高危型人乳头瘤病毒感染和高级别宫颈病变相关的因素:一项在巴拉圭开展的基于人群的研究。

Factors associated with high-risk human papillomavirus infection and high-grade cervical neoplasia: A population-based study in Paraguay.

机构信息

Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción (IICS-UNA), San Lorenzo, Paraguay.

Hospital Materno Infantil de San Lorenzo, Ministerio de Salud Pública y Bienestar Social, San Lorenzo, Paraguay.

出版信息

PLoS One. 2019 Jun 27;14(6):e0218016. doi: 10.1371/journal.pone.0218016. eCollection 2019.

DOI:10.1371/journal.pone.0218016
PMID:31246959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6597051/
Abstract

BACKGROUND

Cervical cancer (CC) is one of the leading causes of cancer mortality among women from Paraguay, with high incidence and mortality rates (31.2 and 16 per 100 000 women, respectively). Although the risk factors associated with high-risk human papillomavirus (hrHPV) infection and preneoplastic cervical lesions are widely studied, population-based characteristics of particular settings may influence the feasibility of HPV-based CC screening implementation. This study aimed to explore factors associated with hrHPV infection and high-grade cervical neoplasia in hrHPV-positive (hrHPV+) women from Paraguay.

METHODS

A total of 5677 women aged 30-64 years from the Central Department of Paraguay were screened with HPV test (Hybrid Capture 2) and Pap smear. Sociodemographic and risk factor interviews were conducted. hrHPV+ women were referred to colposcopy and women with an abnormal colposcopy had a biopsy taken. The outcomes recorded were the hrHPV status and the presence of high-grade cervical intraepithelial neoplasia or worse (CIN2+) among hrHPV+ women. Associations were investigated using multivariate logistic regressions.

RESULTS

hrHPV prevalence was 13.8% (95%CI 13.0-14.8). This value decreased with the age of women (p-trend<0.001) and increased with the lifetime number of sexual partners (p-trend<0.001) and number of previous female partners of their current male partner if women had had one lifetime sexual partner (p-trend<0.001), increasing from 3.06 (95%CI 0.073-20.9) if partners had had one previous female partner to 9.19 (95%CI 2.36-61.1) if they had had eight or more. In hrHPV+ women, CIN2+ prevalence was 10.7% (95%CI 8.58-13.2) and increased with time since the last Pap smear (p-trend<0.001) and with the increasing number of pregnancies (p-trend = 0.05).

CONCLUSION

In these settings, the sexual behavior of women and their male partners is associated with hrHPV infection. In hrHPV+ women, underscreening practices and multiple pregnancies are associated with CIN2+. This knowledge can contribute to public health policies for CC prevention and control in Paraguay.

摘要

背景

宫颈癌(CC)是巴拉圭女性癌症死亡的主要原因之一,发病率和死亡率均较高(分别为 31.2 和 16 例/每 10 万女性)。尽管与高危型人乳头瘤病毒(hrHPV)感染和癌前宫颈病变相关的危险因素已得到广泛研究,但特定人群的人口统计学特征可能会影响基于 HPV 的 CC 筛查的实施可行性。本研究旨在探讨与巴拉圭 hrHPV 阳性(hrHPV+)女性的 hrHPV 感染和高级别宫颈病变相关的因素。

方法

共对巴拉圭中央省 5677 名 30-64 岁的女性进行了 HPV 检测(杂交捕获 2 法)和巴氏涂片筛查。进行了社会人口学和危险因素访谈。对 hrHPV+ 女性进行阴道镜检查,如果阴道镜检查异常,则进行活检。记录的结果是 hrHPV+ 女性的 hrHPV 状态以及高级别宫颈上皮内瘤变或更高级别病变(CIN2+)的存在情况。使用多变量逻辑回归分析了相关性。

结果

hrHPV 流行率为 13.8%(95%CI 13.0-14.8)。该值随女性年龄的增加而降低(p-趋势<0.001),随终生性伴侣数量的增加而增加(p-趋势<0.001),且随当前男性伴侣的前女性伴侣数量的增加而增加(如果女性有过一个性伴侣)(p-趋势<0.001),从有一个前女性伴侣的 3.06(95%CI 0.073-20.9)增加到有八个或更多前女性伴侣的 9.19(95%CI 2.36-61.1)。在 hrHPV+ 女性中,CIN2+ 的患病率为 10.7%(95%CI 8.58-13.2),并随上次巴氏涂片检查后的时间(p-趋势<0.001)和妊娠次数的增加而增加(p-趋势=0.05)。

结论

在这些环境中,女性及其男性伴侣的性行为与 hrHPV 感染相关。在 hrHPV+ 女性中,筛查不足和多次妊娠与 CIN2+相关。这些知识可以为巴拉圭的 CC 预防和控制提供公共卫生政策依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9051/6597051/d6eb2e6a863e/pone.0218016.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9051/6597051/7075600962c9/pone.0218016.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9051/6597051/d6eb2e6a863e/pone.0218016.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9051/6597051/7075600962c9/pone.0218016.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9051/6597051/d6eb2e6a863e/pone.0218016.g002.jpg

相似文献

1
Factors associated with high-risk human papillomavirus infection and high-grade cervical neoplasia: A population-based study in Paraguay.与高危型人乳头瘤病毒感染和高级别宫颈病变相关的因素:一项在巴拉圭开展的基于人群的研究。
PLoS One. 2019 Jun 27;14(6):e0218016. doi: 10.1371/journal.pone.0218016. eCollection 2019.
2
The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.年龄和高危型人乳头瘤病毒(hrHPV)状态对持续性 hrHPV 阳性、细胞学阴性筛查样本中高级别宫颈上皮内瘤变(CIN2+)患病率的影响:一项前瞻性队列研究。
BJOG. 2020 Sep;127(10):1260-1267. doi: 10.1111/1471-0528.16250. Epub 2020 May 3.
3
Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.俄罗斯圣彼得堡 30 岁以上女性中高危型人乳头瘤病毒类型及宫颈鳞状上皮内病变的流行情况。
Cancer Epidemiol. 2011 Apr;35(2):160-4. doi: 10.1016/j.canep.2010.08.010. Epub 2010 Sep 29.
4
Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?将致癌性人乳头瘤病毒基因型归因于高级别宫颈上皮内瘤变:哪种类型会导致病变?
Am J Surg Pathol. 2015 Apr;39(4):496-504. doi: 10.1097/PAS.0000000000000342.
5
Genotype, cervical intraepithelial neoplasia, and type-specific cervical intraepithelial neoplasia distributions in hrHPV+ cases referred to colposcopy: A multicenter study of Chinese mainland women.人乳头瘤病毒(hrHPV)阳性病例转诊行阴道镜检查的基因分型、宫颈上皮内瘤变(CIN)和特定型别宫颈上皮内瘤变的分布:一项中国大陆女性的多中心研究。
J Med Virol. 2024 Mar;96(3):e29475. doi: 10.1002/jmv.29475.
6
Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.西班牙加泰罗尼亚地区,在诊断出非典型鳞状细胞意义不明确(ASC-US)后,利用 HPV DNA 检测对宫颈上皮内瘤变 2+(CIN2+)进行预测。
BMC Infect Dis. 2012 Jan 26;12:25. doi: 10.1186/1471-2334-12-25.
7
Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.高危人群中每三年进行一次人乳头瘤病毒检测用于宫颈癌筛查的安全性:来自LAMS研究的经验
J Med Screen. 2008;15(2):97-104. doi: 10.1258/jms.2008.007061.
8
High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.PreTect HPV-Proofer 检测高危型人乳头瘤病毒(hrHPV)E6/E7mRNA 用于检测 HPV DNA 阳性且细胞学正常的女性中宫颈高级别上皮内瘤变和癌症。
J Clin Microbiol. 2012 Jul;50(7):2390-6. doi: 10.1128/JCM.06587-11. Epub 2012 May 2.
9
Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.关于雅培实时高危型人乳头瘤病毒检测在宫颈癌筛查中的临床性能的三年纵向数据。
J Clin Virol. 2016 Mar;76 Suppl 1:S29-S39. doi: 10.1016/j.jcv.2015.11.021. Epub 2015 Nov 19.
10
The impact of human papillomavirus genotype on colposcopic appearance: a cross-sectional analysis.人乳头瘤病毒基因型对阴道镜检查表现的影响:一项横断面分析。
BJOG. 2014 Aug;121(9):1117-26. doi: 10.1111/1471-0528.12668. Epub 2014 Feb 4.

引用本文的文献

1
Prevalence and Risk Factors of Cervical Lesion Among Married Women With Low Socioeconomic Status: A Study Based on a Cervical Cancer Screening Program.社会经济地位低下的已婚女性宫颈病变的患病率及危险因素:一项基于宫颈癌筛查项目的研究
Int J Public Health. 2025 Jun 20;70:1608482. doi: 10.3389/ijph.2025.1608482. eCollection 2025.
2
Exploring the role of cervicovaginal microbiota as risk factor for cervical cancer in Sub-Saharan Africa: a systematic review and meta-analysis : By.探索宫颈阴道微生物群作为撒哈拉以南非洲地区宫颈癌危险因素的作用:一项系统评价和荟萃分析:作者。
BMC Womens Health. 2025 Apr 4;25(1):160. doi: 10.1186/s12905-025-03688-1.
3

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico.波多黎各女性人群样本中肛门生殖器人乳头瘤病毒感染的患病率、基因分型及相关因素
Papillomavirus Res. 2016 Dec;2:89-96. doi: 10.1016/j.pvr.2016.04.002. Epub 2016 Apr 26.
3
Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland.
Genital infections in high-risk human papillomavirus positive Paraguayan women aged 30-64 with and without cervical lesions.
30-64 岁人乳头瘤病毒阳性、有或无宫颈病变的高风险巴拉圭女性的生殖器感染。
PLoS One. 2024 Oct 29;19(10):e0312947. doi: 10.1371/journal.pone.0312947. eCollection 2024.
4
Systematic literature review of primary and secondary cervical cancer prevention programs in South America.南美洲宫颈癌一级和二级预防项目的系统文献综述。
Rev Panam Salud Publica. 2023 Jul 3;47:e96. doi: 10.26633/RPSP.2023.96. eCollection 2023.
5
Human Papillomavirus Prevalence and Associated Factors in Indigenous Women in Ecuador: A Cross-Sectional Analytical Study.厄瓜多尔土著妇女的人乳头瘤病毒患病率及相关因素:一项横断面分析研究。
Infect Dis Rep. 2023 May 18;15(3):267-278. doi: 10.3390/idr15030027.
6
Clinical implementation of a cervical cancer screening program via co-testing at a university hospital.在一所大学医院通过联合检测进行宫颈癌筛查计划的临床实施。
PLoS One. 2022 Dec 1;17(12):e0278476. doi: 10.1371/journal.pone.0278476. eCollection 2022.
7
Changes in High-Risk HPV Infection Prevalence and Associated Factors in Selected Rural Areas of China: A Multicenter Population-Based Study.中国部分农村地区高危型人乳头瘤病毒感染流行率及相关因素的变化:一项基于多中心人群的研究
Front Med (Lausanne). 2022 Jul 12;9:911367. doi: 10.3389/fmed.2022.911367. eCollection 2022.
8
Behavioral factors associated with multiple-type HPV genital infections: data from a cross-sectional study in young women in Brazil.与多型 HPV 生殖器感染相关的行为因素:巴西年轻女性横断面研究的数据。
Reprod Health. 2021 Oct 10;18(1):201. doi: 10.1186/s12978-021-01244-2.
9
Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus.组蛋白去乙酰化酶抑制剂作为对人乳头瘤病毒诱导的宫颈癌的治疗干预措施
Front Cell Dev Biol. 2021 Jan 28;8:592868. doi: 10.3389/fcell.2020.592868. eCollection 2020.
10
and Its Association with Other Sexually Transmitted Coinfection among Sexually Active Women from the Northeast of Brazil.以及巴西东北部性活跃女性中它与其他性传播合并感染的关联。
Interdiscip Perspect Infect Dis. 2020 Oct 29;2020:8838317. doi: 10.1155/2020/8838317. eCollection 2020.
斯威士兰性活跃女性中高危型人乳头瘤病毒的患病率及相关风险因素
PLoS One. 2017 Jan 23;12(1):e0170189. doi: 10.1371/journal.pone.0170189. eCollection 2017.
4
Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries.撒哈拉以南非洲七个国家宫颈癌的社会人口统计学和生殖决定因素
Cancer Causes Control. 2016 Dec;27(12):1437-1446. doi: 10.1007/s10552-016-0823-5. Epub 2016 Nov 7.
5
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.激素因素对宫颈癌及癌前病变发生风险的影响:欧洲癌症与营养前瞻性调查(EPIC)队列研究结果
PLoS One. 2016 Jan 25;11(1):e0147029. doi: 10.1371/journal.pone.0147029. eCollection 2016.
6
Human papillomavirus and other genital infections in indigenous women from Paraguay: a cross-sectional analytical study.巴拉圭原住民女性中的人乳头瘤病毒及其他生殖器感染:一项横断面分析研究。
BMC Infect Dis. 2013 Nov 9;13:531. doi: 10.1186/1471-2334-13-531.
7
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.有关人乳头瘤病毒检测在宫颈癌二级预防中的证据。
Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095.
8
Introduction of human papillomavirus DNA screening in the world: 15 years of experience.人乳头瘤病毒 DNA 筛查在全球的应用:15 年经验。
Vaccine. 2012 Nov 20;30 Suppl 5:F117-22. doi: 10.1016/j.vaccine.2012.05.071.
9
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.全球女性持续性生殖器人乳头瘤病毒感染模式:文献回顾和荟萃分析。
Int J Cancer. 2013 Sep 15;133(6):1271-85. doi: 10.1002/ijc.27828. Epub 2012 Oct 11.
10
Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.在巴拉圭,对 432 例浸润性宫颈癌进行了人乳头瘤病毒(HPV)型别分析。
J Med Virol. 2012 Oct;84(10):1628-35. doi: 10.1002/jmv.23373.